They present CDG-II type serum transferrin profile related to steatosis, elevated serum levels of ALT and ALP, hypercholesterolemia, low serum Cp and slightly alterations of copper metabolism; they do not develop hepatosplenomegaly or neuropsychiatric disturbances [121,122]. This evidence concerns the gene CP and Hepatosplenomegaly.